XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

Realtime	Geld	Brief	Zeit
	37,200	38,400	20:40
	37,200	38,400	20:31

Realtime

Geld

Brief

Zeit

37,200

38,400

20:40

37,200

38,400

20:31

XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.

THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:

INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
CARLTON PRECIOUS O.N. IVH CA14306B1076
LODESTAR METALS CORP. PR9 CA54020J1012
PEGASUS MERCANTILE INC. U04 CA70557Y1051
RUBELLITE ENERGY CORP. 6L00 CA7811131050
KEZAR LIFE SC.NEW DL-,001 2KZ0 US49372L2097
MAGNERA CORP. WI DL-,01 W2B US55939A1079
MIND TECHNOL. NEW DL-,01 MI70 US6025663096
MONOPAR THERAP. NEW 1IY0 US61023L2079
NRX PHARM.INC. NEW O.N. B1Q US6294442099
PALVELLA THERAPEUTICS NEW PI6 US6979471090
AB/FROM ONWARDS 17.01.2025 09:41 CET

Zeit	Aktuelle Nachrichten
19.03.	Carlton Precious Inc.: Carlton Precious Samples High Grade Silver and Gold Veins at Esquilache	TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI \| OTCQB: NBRFF) ("Carlton" or the "Company") is pleased to report that it has received assay results from recent surface... ► Artikel lesen
17.01.	XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
08.01.	XFRA IVH: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARLTON PRECIOUS... ► Artikel lesen
08.01.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 08.01.2025	The following instruments on XETRA do have their first trading 08.01.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 08.01.2025 Aktien 1 CA14306B1076 Carlton Precious Inc. 2... ► Artikel lesen
07.01.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.01.2025	The following instruments on Boerse Frankfurt do have their last trading day on 07.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.01.2025ISIN NameFR0004152882 CLASQUIN... ► Artikel lesen

Zeit

Aktuelle Nachrichten

19.03.

Carlton Precious Inc.: Carlton Precious Samples High Grade Silver and Gold Veins at Esquilache

TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI | OTCQB: NBRFF) ("Carlton" or the "Company") is pleased to report that it has received assay results from recent surface...
► Artikel lesen

17.01.

XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

08.01.

XFRA IVH: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARLTON PRECIOUS...
► Artikel lesen

08.01.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 08.01.2025

The following instruments on XETRA do have their first trading 08.01.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 08.01.2025 Aktien 1 CA14306B1076 Carlton Precious Inc. 2...
► Artikel lesen

07.01.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.01.2025

The following instruments on Boerse Frankfurt do have their last trading day on 07.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.01.2025ISIN NameFR0004152882 CLASQUIN...
► Artikel lesen

Zeit	Aktuelle Nachrichten
01.04.	Kezar Life Sciences, Inc. - 8-K, Current Report
25.03.	Kezar Life Sciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans
25.03.	Kezar drops after Q4 results and mid-stage data for lead asset
25.03.	Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug Candidate
25.03.	Kezar berichtet über positive AIH-Studienergebnisse und Finanzen für 2024

Zeit

Aktuelle Nachrichten

01.04.

Kezar Life Sciences, Inc. - 8-K, Current Report

25.03.

Kezar Life Sciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans

25.03.

Kezar drops after Q4 results and mid-stage data for lead asset

25.03.

Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug Candidate

25.03.

Kezar berichtet über positive AIH-Studienergebnisse und Finanzen für 2024

Zeit	Aktuelle Nachrichten
Mi	Lodestar Metals Corp: Lodestar to settle debt owed to Silver One
Mi	Lodestar Metals Corp.: Lodestar Metals Settles Indebtedness with Silver One Resources Inc.	Vancouver, British Columbia--(Newsfile Corp. - April 22, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) ("Lodestar" or the "Company"), announces that it has entered into a settlement agreement... ► Artikel lesen
17.01.	XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
07.12.24	Lodestar Metals Corp: Lodestar files AGM materials on SEDAR+
07.12.24	Lodestar Metals Corp.: Lodestar Metals Provides Details of Annual General Meeting	Vancouver, British Columbia--(Newsfile Corp. - December 6, 2024) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) ("Lodestar" or the "Company"), announces that it will be relying on CSA Coordinated... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Lodestar Metals Corp: Lodestar to settle debt owed to Silver One

Lodestar Metals Corp.: Lodestar Metals Settles Indebtedness with Silver One Resources Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 22, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) ("Lodestar" or the "Company"), announces that it has entered into a settlement agreement...
► Artikel lesen

17.01.

XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

07.12.24

Lodestar Metals Corp: Lodestar files AGM materials on SEDAR+

07.12.24

Lodestar Metals Corp.: Lodestar Metals Provides Details of Annual General Meeting

Vancouver, British Columbia--(Newsfile Corp. - December 6, 2024) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) ("Lodestar" or the "Company"), announces that it will be relying on CSA Coordinated...
► Artikel lesen

Zeit	Aktuelle Nachrichten
14.04.	Magnera Corporation: Magnera to Report 2025 Second Quarter Results on May 7th
28.03.	Magnera Corporation (MAGN): A Bull Case Theory
24.03.	Should You Invest in Magnera Corporation (MAGN)?
03.03.	Hedge Fund and Insider Trading News: Ray Dalio, Israel Englander, Warren Buffett, Bill Ackman, Lone Pine Capital, Elliott Management, Gotham Asset Management, Magnera Corp (MAGN), Walmart Inc (WMT), and More
06.02.	Magnera Corp - 10-Q, Quarterly Report

Zeit

Aktuelle Nachrichten

14.04.

Magnera Corporation: Magnera to Report 2025 Second Quarter Results on May 7th

28.03.

Magnera Corporation (MAGN): A Bull Case Theory

24.03.

Should You Invest in Magnera Corporation (MAGN)?

03.03.

Hedge Fund and Insider Trading News: Ray Dalio, Israel Englander, Warren Buffett, Bill Ackman, Lone Pine Capital, Elliott Management, Gotham Asset Management, Magnera Corp (MAGN), Walmart Inc (WMT), and More

06.02.

Magnera Corp - 10-Q, Quarterly Report

Zeit	Aktuelle Nachrichten
Di	MIND Technology GAAP EPS of $0.25, revenue of $15M beats by $2.8M
Di	MIND TECHNOLOGY, INC - 8-K, Current Report
Di	Mind Technology, Inc. Reports Fiscal 2025 Fourth Quarter And Year-end Results	THE WOODLANDS, Texas, April 22, 2025 /PRNewswire/ -- MIND Technology, Inc. (NASDAQ: MIND) ("MIND" or the "Company") today announced financial results for its... ► Artikel lesen
Mo	Earnings Preview For MIND Technology
Mo	MIND Technology: Quartalszahlen und Marktentwicklung im Fokus

Zeit

Aktuelle Nachrichten

MIND Technology GAAP EPS of $0.25, revenue of $15M beats by $2.8M

MIND TECHNOLOGY, INC - 8-K, Current Report

Mind Technology, Inc. Reports Fiscal 2025 Fourth Quarter And Year-end Results

THE WOODLANDS, Texas, April 22, 2025 /PRNewswire/ -- MIND Technology, Inc. (NASDAQ: MIND) ("MIND" or the "Company") today announced financial results for its...
► Artikel lesen

Earnings Preview For MIND Technology

MIND Technology: Quartalszahlen und Marktentwicklung im Fokus

Zeit	Aktuelle Nachrichten
02.04.	Jones Trading cuts Monopar stock rating post-earnings
31.03.	Monopar Therapeutics GAAP EPS of -$2.23
31.03.	Monopar Therapeutics - 8-K, Current Report
31.03.	Monopar Therapeutics - S-8, Securities to be offered to employees in employee benefit plans
31.03.	Monopar Therapeutics - 10-K, Annual Report

Zeit

Aktuelle Nachrichten

02.04.

Jones Trading cuts Monopar stock rating post-earnings

31.03.

Monopar Therapeutics GAAP EPS of -$2.23

31.03.

Monopar Therapeutics - 8-K, Current Report

31.03.

Monopar Therapeutics - S-8, Securities to be offered to employees in employee benefit plans

31.03.

Monopar Therapeutics - 10-K, Annual Report

Zeit	Aktuelle Nachrichten
17.04.	NRX Pharmaceuticals, Inc. - 8-K, Current Report
03.04.	HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE	Investment to support initiation of HOPE's network of clinics to treat suicidal depression and PTSD with ketamine, TMS and other modalities MIAMI, April 3, 2025 /PRNewswire/ --... ► Artikel lesen
02.04.	BTIG initiates NRx Pharmaceuticals with $18 price target
31.03.	NRx Pharma: HOPE Therapeutics Signs Deal To Buy Dura Medical
31.03.	NRx Pharmaceuticals' Hope Therapeutics to acquire Dura Medical, no terms

Zeit

Aktuelle Nachrichten

17.04.

NRX Pharmaceuticals, Inc. - 8-K, Current Report

03.04.

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

Investment to support initiation of HOPE's network of clinics to treat suicidal depression and PTSD with ketamine, TMS and other modalities MIAMI, April 3, 2025 /PRNewswire/ --...
► Artikel lesen

02.04.

BTIG initiates NRx Pharmaceuticals with $18 price target

31.03.

NRx Pharma: HOPE Therapeutics Signs Deal To Buy Dura Medical

31.03.

NRx Pharmaceuticals' Hope Therapeutics to acquire Dura Medical, no terms

Zeit	Aktuelle Nachrichten
Mi	Palvella Therapeutics Inc.: Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of ...
Di	Palvella Therapeutics secures new patent for rare skin disease gel
Di	Palvella Therapeutics Inc.: Palvella Therapeutics Granted Additional U.S. Patent for QTORIN Rapamycin for the Treatment of Microcystic Lymphatic Malformations	Fifth issued patent in the U.S. for QTORIN rapamycin with anticipated patent life extending into 2038 QTORIN rapamycin has the potential to be the first approved therapy and standard of care for microcystic... ► Artikel lesen
11.04.	Palvella Therapeutics Inc.: Palvella Therapeutics Announces QTORIN Rapamycin 3.9% Anhydrous Gel for the Treatment of Microcystic Lymphatic Malformations Featured in Oral Presentation by Amy Paller, M.S., M.D., Chair of Dermatology ...	Presentation highlighted the recent expansion of the Phase 3 SELVA trial to include children 3 to 5 years old Presentation reviewed clinically and statistically significant Phase 2 results and... ► Artikel lesen
09.04.	Chardan sets $50 target on Palvella Therapeutics stock

Zeit

Aktuelle Nachrichten

Palvella Therapeutics Inc.: Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of ...

Palvella Therapeutics secures new patent for rare skin disease gel

Palvella Therapeutics Inc.: Palvella Therapeutics Granted Additional U.S. Patent for QTORIN Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Fifth issued patent in the U.S. for QTORIN rapamycin with anticipated patent life extending into 2038 QTORIN rapamycin has the potential to be the first approved therapy and standard of care for microcystic...
► Artikel lesen

11.04.

Palvella Therapeutics Inc.: Palvella Therapeutics Announces QTORIN Rapamycin 3.9% Anhydrous Gel for the Treatment of Microcystic Lymphatic Malformations Featured in Oral Presentation by Amy Paller, M.S., M.D., Chair of Dermatology ...

Presentation highlighted the recent expansion of the Phase 3 SELVA trial to include children 3 to 5 years old Presentation reviewed clinically and statistically significant Phase 2 results and...
► Artikel lesen

09.04.

Chardan sets $50 target on Palvella Therapeutics stock

Zeit	Aktuelle Nachrichten
16.04.	Pegasus Mercantile Inc (2): Pegasus Mercantile files fiscal Q1 financial statements
16.04.	Pegasus Mercantile zeigt finanzielle Herausforderungen trotz Verbesserungen
14.04.	Pegasus Mercantile Inc (2): Pegasus Mercantile files 2024 financials, working on Q1
28.03.	Pegasus Mercantile Inc (2): Pegasus Mercantile to file fiscal 2024 results April 14
12.03.	Pegasus Mercantile Inc (2): Pegasus Mercantile has no material changes

Zeit

Aktuelle Nachrichten

16.04.

Pegasus Mercantile Inc (2): Pegasus Mercantile files fiscal Q1 financial statements

16.04.

Pegasus Mercantile zeigt finanzielle Herausforderungen trotz Verbesserungen

14.04.

Pegasus Mercantile Inc (2): Pegasus Mercantile files 2024 financials, working on Q1

28.03.

Pegasus Mercantile Inc (2): Pegasus Mercantile to file fiscal 2024 results April 14

12.03.

Pegasus Mercantile Inc (2): Pegasus Mercantile has no material changes

Zeit	Aktuelle Nachrichten
11.03.	Rubellite Energy reports Q4 results
11.03.	Rubellite Energy Corp. Reports Fourth Quarter 2024 Financial And Operating Results, Year-end 2024 Reserves, Provides Operations Update And First Quarter And Full Year 2025 Guidance
17.01.	XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
13.11.24	Rubellite Energy reports Q3 results
12.11.24	Rubellite Energy Corp. Reports Third Quarter Financial And Operating Results

Zeit

Aktuelle Nachrichten

11.03.

Rubellite Energy reports Q4 results

11.03.

Rubellite Energy Corp. Reports Fourth Quarter 2024 Financial And Operating Results, Year-end 2024 Reserves, Provides Operations Update And First Quarter And Full Year 2025 Guidance

17.01.

XFRA IVH,PR9,U04,6L00,2KZ0,W2B,MI70,1IY0,B1Q,PI6: WIEDERAUFNAHME/RESUMPTION

13.11.24

Rubellite Energy reports Q3 results

12.11.24

Rubellite Energy Corp. Reports Third Quarter Financial And Operating Results

Unternehmen / Aktien	Kurs	%
CARLTON PRECIOUS INC	0,056	+13,13 %
KEZAR LIFE SCIENCES INC	3,900	+0,52 %
LODESTAR METALS CORP	0,005	0,00 %
MAGNERA CORPORATION	12,000	0,00 %
MIND TECHNOLOGY INC	4,520	0,00 %
MONOPAR THERAPEUTICS INC	37,200	+1,09 %
NRX PHARMACEUTICALS INC	1,590	-4,22 %
PALVELLA THERAPEUTICS INC	23,400	+5,41 %
PEGASUS MERCANTILE INC	0,070	0,00 %
RUBELLITE ENERGY CORP	1,060	+3,92 %

Unternehmen / Aktien

Kurs

CARLTON PRECIOUS INC

0,056

+13,13 %

KEZAR LIFE SCIENCES INC

3,900

+0,52 %

LODESTAR METALS CORP

0,005

0,00 %

MAGNERA CORPORATION